Michael B Wallace
Overview
Explore the profile of Michael B Wallace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
406
Citations
7466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osagiede O, Wallace M
Gastrointest Endosc Clin N Am
. 2025 Feb;
35(2):419-430.
PMID: 40021238
Artificial intelligence (AI) application in gastroenterology has grown in the last decade and continues to evolve very rapidly. Early promising results have opened the door to explore its potential application...
2.
Danpanichkul P, Pang Y, Inkongngam T, Namsathimaphorn K, Rakwong K, Kaeosri C, et al.
Cancer Commun (Lond)
. 2025 Feb;
PMID: 40017390
No abstract available.
3.
Danpanichkul P, Suparan K, Auttapracha T, Tothanarungroj P, Kongarin S, Rakwong K, et al.
Mayo Clin Proc
. 2025 Feb;
PMID: 39945699
Objective: To explore the increasing incidence of gastrointestinal (GI) cancers and related risk factors in younger patients. Patient And Methods: We used data from the Global Burden of Disease Study...
4.
Kolb J, Monachese M, Rubin R, Wang T, Choi A, Bazarbashi A, et al.
Clin Gastroenterol Hepatol
. 2025 Feb;
PMID: 39892628
Background And Aims: Endoscopic ultrasound-guided portosystemic pressure gradient measurement (EUS-PPG) is a novel technique to evaluate for portal hypertension (PH), a diagnosis that can prognosticate and guide therapy for patients....
5.
Danpanichkul P, Suparan K, Pang Y, Auttapracha T, Tham E, Srisurapanont K, et al.
Am J Med
. 2025 Jan;
PMID: 39778787
Objective: Gastrointestinal (GI) cancers account for one-third of global cancer mortality, with nearly half being preventable. This study updates the global burden of GI cancers attributed to major risk factors....
6.
Seyithanoglu D, Durak G, Keles E, Medetalibeyoglu A, Hong Z, Zhang Z, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766167
Pancreatic cystic lesions (PCLs) represent a spectrum of non-neoplasms and neoplasms with varying malignant potential, posing significant challenges in diagnosis and management. While some PCLs are precursors to pancreatic cancer,...
7.
Antony A, Mukherjee S, Bi Y, Collisson E, Nagaraj M, Murlidhar M, et al.
Abdom Radiol (NY)
. 2024 Dec;
PMID: 39738571
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the United States, largely due to its poor five-year survival rate and frequent late-stage diagnosis. A significant...
8.
Shah S, Wang A, Wallace M, Hwang J
Gastroenterology
. 2024 Dec;
168(2):405-416.e1.
PMID: 39718517
Description: Gastric cancer (GC) is a leading cause of preventable cancer and mortality in certain US populations. The most impactful way to reduce GC mortality is via primary prevention, namely...
9.
Aldhaleei W, Kapoor E, Shufelt C, Wallace M, Kling J, Cole K, et al.
Menopause
. 2024 Dec;
32(2):121-127.
PMID: 39689247
Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) and vasomotor symptoms (VMS) are associated with increased cardiovascular disease risk. Although visceral adiposity has been linked to MASLD and VMS independently, this...
10.
Zhang Z, Keles E, Durak G, Taktak Y, Susladkar O, Gorade V, et al.
Med Image Anal
. 2024 Nov;
99:103382.
PMID: 39541706
Automated volumetric segmentation of the pancreas on cross-sectional imaging is needed for diagnosis and follow-up of pancreatic diseases. While CT-based pancreatic segmentation is more established, MRI-based segmentation methods are understudied,...